Literature DB >> 22815489

Factor h and properdin recognize different epitopes on renal tubular epithelial heparan sulfate.

Azadeh Zaferani1, Romain R Vivès, Pieter van der Pol, Gerjan J Navis, Mohamed R Daha, Cees van Kooten, Hugues Lortat-Jacob, Marc A Seelen, Jacob van den Born.   

Abstract

During proteinuria, renal tubular epithelial cells become exposed to ultrafiltrate-derived serum proteins, including complement factors. Recently, we showed that properdin binds to tubular heparan sulfates (HS). We now document that factor H also binds to tubular HS, although to a different epitope than properdin. Factor H was present on the urinary side of renal tubular cells in proteinuric, but not in normal renal tissues and colocalized with properdin in proteinuric kidneys. Factor H dose-dependently bound to proximal tubular epithelial cells (PTEC) in vitro. Preincubation of factor H with exogenous heparin and pretreatment of PTECs with heparitinase abolished the binding to PTECs. Surface plasmon resonance experiments showed high affinity of factor H for heparin and HS (K(D) values of 32 and 93 nm, respectively). Using a library of HS-like polysaccharides, we showed that chain length and high sulfation density are the most important determinants for glycosaminoglycan-factor H interaction and clearly differ from properdin-heparinoid interaction. Coincubation of properdin and factor H did not hamper HS/heparin binding of one another, indicating recognition of different nonoverlapping epitopes on HS/heparin by factor H and properdin. Finally we showed that certain low anticoagulant heparinoids can inhibit properdin binding to tubular HS, with a minor effect on factor H binding to tubular HS. As a result, these heparinoids can control the alternative complement pathway. In conclusion, factor H and properdin interact with different HS epitopes of PTECs. These interactions can be manipulated with some low anticoagulant heparinoids, which can be important for preventing complement-derived tubular injury in proteinuric renal diseases.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22815489      PMCID: PMC3438980          DOI: 10.1074/jbc.M112.380386

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  49 in total

1.  Biosynthesis of heparin. Assay and properties of the microsomal uronosyl C-5 epimerase.

Authors:  G Bäckström; M Höök; U Lindahl; D S Feingold; A Malmström; L Rodén; I Jacobsson
Journal:  J Biol Chem       Date:  1979-04-25       Impact factor: 5.157

2.  Biosynthesis of complement factor H by human umbilical vein endothelial cells. Regulation by T cell growth factor and IFN-gamma.

Authors:  R A Brooimans; P S Hiemstra; A A van der Ark; R B Sim; L A van Es; M R Daha
Journal:  J Immunol       Date:  1989-03-15       Impact factor: 5.422

3.  Heparin and modified heparin inhibit complement activation in vivo.

Authors:  J M Weiler; R E Edens; R J Linhardt; D P Kapelanski
Journal:  J Immunol       Date:  1992-05-15       Impact factor: 5.422

4.  Isolation, characterization, and mechanism of action of rat beta 1H.

Authors:  M R Daha; L A van Es
Journal:  J Immunol       Date:  1982-04       Impact factor: 5.422

5.  Heparin prevents formation of the human C3 amplification convertase by inhibiting the binding site for B on C3b.

Authors:  F Maillet; M D Kazatchkine; D Glotz; E Fischer; M Rowe
Journal:  Mol Immunol       Date:  1983-12       Impact factor: 4.407

6.  Sulfation of some chemically-modified heparins. Formation of a 3-sulfate analog of heparin.

Authors:  R N Rej; K G Ludwig-Baxter; A S Perlin
Journal:  Carbohydr Res       Date:  1991-03-20       Impact factor: 2.104

7.  Structure-function relationships in the inhibitory effect of heparin on complement activation: independency of the anti-coagulant and anti-complementary sites on the heparin molecule.

Authors:  F Maillet; M Petitou; J Choay; M D Kazatchkine
Journal:  Mol Immunol       Date:  1988-09       Impact factor: 4.407

8.  Presence of N-unsubstituted glucosamine units in native heparan sulfate revealed by a monoclonal antibody.

Authors:  J van den Born; K Gunnarsson; M A Bakker; L Kjellén; M Kusche-Gullberg; M Maccarana; J H Berden; U Lindahl
Journal:  J Biol Chem       Date:  1995-12-29       Impact factor: 5.157

9.  Protein load impairs factor H binding promoting complement-dependent dysfunction of proximal tubular cells.

Authors:  Simona Buelli; Mauro Abbate; Marina Morigi; Daniela Moioli; Cristina Zanchi; Marina Noris; Carla Zoja; Charles D Pusey; Peter F Zipfel; Giuseppe Remuzzi
Journal:  Kidney Int       Date:  2009-02-25       Impact factor: 10.612

10.  Inhibition of complement activation by natural sulfated polysaccharides (fucans) from brown seaweed.

Authors:  C Blondin; E Fischer; C Boisson-Vidal; M D Kazatchkine; J Jozefonvicz
Journal:  Mol Immunol       Date:  1994-03       Impact factor: 4.407

View more
  28 in total

Review 1.  Complement activation, regulation, and molecular basis for complement-related diseases.

Authors:  Goran Bajic; Søren E Degn; Steffen Thiel; Gregers R Andersen
Journal:  EMBO J       Date:  2015-10-21       Impact factor: 11.598

Review 2.  Complement activation in progressive renal disease.

Authors:  Amy Fearn; Neil Stephen Sheerin
Journal:  World J Nephrol       Date:  2015-02-06

3.  Functional and structural insight into properdin control of complement alternative pathway amplification.

Authors:  Dennis V Pedersen; Lubka Roumenina; Rasmus K Jensen; Trine Af Gadeberg; Chiara Marinozzi; Capucine Picard; Tania Rybkine; Steffen Thiel; Uffe Bs Sørensen; Cordula Stover; Veronique Fremeaux-Bacchi; Gregers R Andersen
Journal:  EMBO J       Date:  2017-03-06       Impact factor: 11.598

4.  Properdin binding to complement activating surfaces depends on initial C3b deposition.

Authors:  Morten Harboe; Christina Johnson; Stig Nymo; Karin Ekholt; Camilla Schjalm; Julie K Lindstad; Anne Pharo; Bernt Christian Hellerud; Kristina Nilsson Ekdahl; Tom Eirik Mollnes; Per H Nilsson
Journal:  Proc Natl Acad Sci U S A       Date:  2017-01-09       Impact factor: 11.205

Review 5.  Glomerular basement membrane heparan sulfate in health and disease: A regulator of local complement activation.

Authors:  Dorin-Bogdan Borza
Journal:  Matrix Biol       Date:  2016-09-06       Impact factor: 11.583

6.  High-density lipoproteins are a potential therapeutic target for age-related macular degeneration.

Authors:  Una L Kelly; Daniel Grigsby; Martha A Cady; Michael Landowski; Nikolai P Skiba; Jian Liu; Alan T Remaley; Mikael Klingeborn; Catherine Bowes Rickman
Journal:  J Biol Chem       Date:  2020-07-31       Impact factor: 5.157

Review 7.  Properdin in complement activation and tissue injury.

Authors:  Allison M Lesher; Bo Nilsson; Wen-Chao Song
Journal:  Mol Immunol       Date:  2013-06-29       Impact factor: 4.407

8.  Serum properdin consumption as a biomarker of C5 convertase dysregulation in C3 glomerulopathy.

Authors:  F Corvillo; M Bravo García-Morato; P Nozal; S Garrido; A Tortajada; S Rodríguez de Córdoba; M López-Trascasa
Journal:  Clin Exp Immunol       Date:  2016-01-22       Impact factor: 4.330

9.  Complement factor P is a ligand for the natural killer cell-activating receptor NKp46.

Authors:  Laurent Gauthier; Myriam Baratin; Sophie Guia; Aurore Fenis; Emilie Narni-Mancinelli; Ala-Eddine Deghmane; Benjamin Rossi; Patrick Fourquet; Bertrand Escalière; Yann M Kerdiles; Sophie Ugolini; Muhamed-Kheir Taha; Eric Vivier
Journal:  Sci Immunol       Date:  2017-04-28

Review 10.  The role of complement in age-related macular degeneration: heparan sulphate, a ZIP code for complement factor H?

Authors:  Alex Langford-Smith; Tiarnan D L Keenan; Simon J Clark; Paul N Bishop; Anthony J Day
Journal:  J Innate Immun       Date:  2013-12-07       Impact factor: 7.349

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.